CN112226495B - 一种dna同源重组异常的检测方法及其应用 - Google Patents
一种dna同源重组异常的检测方法及其应用 Download PDFInfo
- Publication number
- CN112226495B CN112226495B CN202011504812.1A CN202011504812A CN112226495B CN 112226495 B CN112226495 B CN 112226495B CN 202011504812 A CN202011504812 A CN 202011504812A CN 112226495 B CN112226495 B CN 112226495B
- Authority
- CN
- China
- Prior art keywords
- snp
- sequence
- site
- screening
- sample
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 230000005856 abnormality Effects 0.000 title claims abstract description 7
- 230000006801 homologous recombination Effects 0.000 title claims abstract description 7
- 238000002744 homologous recombination Methods 0.000 title claims abstract description 7
- 238000000034 method Methods 0.000 title abstract description 20
- 239000000523 sample Substances 0.000 claims abstract description 58
- 238000012216 screening Methods 0.000 claims abstract description 22
- 238000012163 sequencing technique Methods 0.000 claims abstract description 12
- 238000004458 analytical method Methods 0.000 claims abstract description 9
- 238000001276 Kolmogorov–Smirnov test Methods 0.000 claims abstract description 8
- 238000012165 high-throughput sequencing Methods 0.000 claims abstract description 5
- 238000001914 filtration Methods 0.000 claims description 12
- 230000003252 repetitive effect Effects 0.000 claims description 12
- 230000035772 mutation Effects 0.000 claims description 10
- 230000036438 mutation frequency Effects 0.000 claims description 10
- 238000011144 upstream manufacturing Methods 0.000 claims description 8
- 238000013461 design Methods 0.000 claims description 7
- 238000001514 detection method Methods 0.000 claims description 7
- 239000013068 control sample Substances 0.000 claims description 5
- 238000012217 deletion Methods 0.000 claims description 5
- 230000037430 deletion Effects 0.000 claims description 5
- 210000002593 Y chromosome Anatomy 0.000 claims description 4
- 230000002438 mitochondrial effect Effects 0.000 claims description 4
- 238000003908 quality control method Methods 0.000 claims description 4
- 238000002405 diagnostic procedure Methods 0.000 claims 1
- 108020004414 DNA Proteins 0.000 description 16
- 210000001519 tissue Anatomy 0.000 description 8
- 208000031448 Genomic Instability Diseases 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 7
- 239000008280 blood Substances 0.000 description 7
- 230000034431 double-strand break repair via homologous recombination Effects 0.000 description 6
- 206010028980 Neoplasm Diseases 0.000 description 4
- 206010033128 Ovarian cancer Diseases 0.000 description 4
- 206010061535 Ovarian neoplasm Diseases 0.000 description 4
- 239000012661 PARP inhibitor Substances 0.000 description 4
- 229940121906 Poly ADP ribose polymerase inhibitor Drugs 0.000 description 4
- 230000001186 cumulative effect Effects 0.000 description 4
- 239000012188 paraffin wax Substances 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 231100000241 scar Toxicity 0.000 description 4
- 230000035945 sensitivity Effects 0.000 description 4
- 108700028369 Alleles Proteins 0.000 description 3
- 238000007400 DNA extraction Methods 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 238000005315 distribution function Methods 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 238000013508 migration Methods 0.000 description 3
- 230000005012 migration Effects 0.000 description 3
- 230000008439 repair process Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 108091035539 telomere Proteins 0.000 description 3
- 210000003411 telomere Anatomy 0.000 description 3
- 102000055501 telomere Human genes 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 102000036365 BRCA1 Human genes 0.000 description 2
- 108700020463 BRCA1 Proteins 0.000 description 2
- 101150072950 BRCA1 gene Proteins 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000002096 quantum dot Substances 0.000 description 2
- GUAHPAJOXVYFON-ZETCQYMHSA-N (8S)-8-amino-7-oxononanoic acid zwitterion Chemical compound C[C@H](N)C(=O)CCCCCC(O)=O GUAHPAJOXVYFON-ZETCQYMHSA-N 0.000 description 1
- 102000000872 ATM Human genes 0.000 description 1
- 108010004586 Ataxia Telangiectasia Mutated Proteins Proteins 0.000 description 1
- 108700040618 BRCA1 Genes Proteins 0.000 description 1
- 102000052609 BRCA2 Human genes 0.000 description 1
- 108700020462 BRCA2 Proteins 0.000 description 1
- 101100381981 Caenorhabditis elegans bam-2 gene Proteins 0.000 description 1
- 208000005623 Carcinogenesis Diseases 0.000 description 1
- 206010008342 Cervix carcinoma Diseases 0.000 description 1
- 208000032544 Cicatrix Diseases 0.000 description 1
- 241000037488 Coccoloba pubescens Species 0.000 description 1
- 102100038111 Cyclin-dependent kinase 12 Human genes 0.000 description 1
- 230000033616 DNA repair Effects 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 102000016627 Fanconi Anemia Complementation Group N protein Human genes 0.000 description 1
- 108010067741 Fanconi Anemia Complementation Group N protein Proteins 0.000 description 1
- 206010064571 Gene mutation Diseases 0.000 description 1
- 101000884345 Homo sapiens Cyclin-dependent kinase 12 Proteins 0.000 description 1
- 101000777277 Homo sapiens Serine/threonine-protein kinase Chk2 Proteins 0.000 description 1
- 108010068097 Rad51 Recombinase Proteins 0.000 description 1
- 102000002490 Rad51 Recombinase Human genes 0.000 description 1
- 108091081062 Repeated sequence (DNA) Proteins 0.000 description 1
- 101100495925 Schizosaccharomyces pombe (strain 972 / ATCC 24843) chr3 gene Proteins 0.000 description 1
- 102100031075 Serine/threonine-protein kinase Chk2 Human genes 0.000 description 1
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 239000000090 biomarker Substances 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 230000036952 cancer formation Effects 0.000 description 1
- 231100000504 carcinogenesis Toxicity 0.000 description 1
- 201000010881 cervical cancer Diseases 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000005782 double-strand break Effects 0.000 description 1
- 230000011559 double-strand break repair via nonhomologous end joining Effects 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000012854 evaluation process Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000000873 masking effect Effects 0.000 description 1
- 230000011987 methylation Effects 0.000 description 1
- 238000007069 methylation reaction Methods 0.000 description 1
- 238000007481 next generation sequencing Methods 0.000 description 1
- 230000008261 resistance mechanism Effects 0.000 description 1
- 230000037387 scars Effects 0.000 description 1
- 238000002864 sequence alignment Methods 0.000 description 1
- 230000019491 signal transduction Effects 0.000 description 1
- 230000005783 single-strand break Effects 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6858—Allele-specific amplification
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
- G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
- G16B25/20—Polymerase chain reaction [PCR]; Primer or probe design; Probe optimisation
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Biophysics (AREA)
- Theoretical Computer Science (AREA)
- Zoology (AREA)
- Medical Informatics (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Analytical Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Evolutionary Biology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Computational Biology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011504812.1A CN112226495B (zh) | 2020-12-18 | 2020-12-18 | 一种dna同源重组异常的检测方法及其应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011504812.1A CN112226495B (zh) | 2020-12-18 | 2020-12-18 | 一种dna同源重组异常的检测方法及其应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN112226495A CN112226495A (zh) | 2021-01-15 |
CN112226495B true CN112226495B (zh) | 2021-03-16 |
Family
ID=74124914
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202011504812.1A Active CN112226495B (zh) | 2020-12-18 | 2020-12-18 | 一种dna同源重组异常的检测方法及其应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112226495B (zh) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112820351A (zh) * | 2021-03-01 | 2021-05-18 | 江苏医联生物科技有限公司 | 检测肿瘤患者的突变和hrd评分指导用药的方法 |
CN112980834B (zh) * | 2021-04-22 | 2021-08-17 | 菁良基因科技(深圳)有限公司 | 一种同源重组修复缺陷参考品及其制备方法和试剂盒 |
CN114999568B (zh) * | 2021-06-28 | 2023-04-18 | 北京橡鑫生物科技有限公司 | 一种端粒等位基因不平衡tai的计算方法 |
CN113462784B (zh) * | 2021-08-31 | 2021-12-10 | 迈杰转化医学研究(苏州)有限公司 | 一种构建用于同源重组修复缺陷检测的靶标集合的方法 |
CN114317753A (zh) * | 2021-12-30 | 2022-04-12 | 北京迈基诺基因科技股份有限公司 | 眼肿瘤融合基因的检测模型及构建方法和检测方法 |
CN114678067B (zh) * | 2022-03-21 | 2023-03-14 | 纳昂达(南京)生物科技有限公司 | 构建多人群非外显子区snp探针集合的方法及装置 |
CN114990207A (zh) * | 2022-06-13 | 2022-09-02 | 迈基诺(重庆)基因科技有限责任公司 | 用于检测染色体非整倍体及单基因突变的试剂盒及应用 |
CN114841294B (zh) * | 2022-07-04 | 2022-10-28 | 杭州德适生物科技有限公司 | 一种检测染色体结构异常的分类器模型训练方法及装置 |
CN115985399B (zh) * | 2023-03-20 | 2023-07-04 | 广州迈景基因医学科技有限公司 | 用于高通量测序的HRD panel位点选择优化方法及*** |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014048062A1 (zh) * | 2012-09-28 | 2014-04-03 | 未名兴旺***作物设计前沿实验室(北京)有限公司 | Snp位点集合及其使用方法与应用 |
CN104160037A (zh) * | 2011-12-21 | 2014-11-19 | 美瑞德生物工程公司 | 用于评估杂合性丢失的方法与材料 |
CN106086013A (zh) * | 2016-06-30 | 2016-11-09 | 厦门艾德生物医药科技股份有限公司 | 一种用于核酸富集捕获的探针及设计方法 |
CN107287285A (zh) * | 2017-03-28 | 2017-10-24 | 上海至本生物科技有限公司 | 一种预测同源重组缺失机制及患者对癌症治疗响应的方法 |
-
2020
- 2020-12-18 CN CN202011504812.1A patent/CN112226495B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104160037A (zh) * | 2011-12-21 | 2014-11-19 | 美瑞德生物工程公司 | 用于评估杂合性丢失的方法与材料 |
WO2014048062A1 (zh) * | 2012-09-28 | 2014-04-03 | 未名兴旺***作物设计前沿实验室(北京)有限公司 | Snp位点集合及其使用方法与应用 |
CN106086013A (zh) * | 2016-06-30 | 2016-11-09 | 厦门艾德生物医药科技股份有限公司 | 一种用于核酸富集捕获的探针及设计方法 |
CN107287285A (zh) * | 2017-03-28 | 2017-10-24 | 上海至本生物科技有限公司 | 一种预测同源重组缺失机制及患者对癌症治疗响应的方法 |
Non-Patent Citations (3)
Title |
---|
Frequent Homologous Recombination Deficiency in High-grade Endometrial Carcinomas;Marthe M.de Jonge,et al;《Clinical Cancer Research》;20181109;全文 * |
Homologous Recombination Deficiency in Breast Cancer:A Clinical Review;Wendie D.ET AL;《JCO Precision Oncology》;20170619;全文 * |
Homologous recombination;Hisamitsu Takaya,et al;《Sci Rep》;20200229;全文 * |
Also Published As
Publication number | Publication date |
---|---|
CN112226495A (zh) | 2021-01-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN112226495B (zh) | 一种dna同源重组异常的检测方法及其应用 | |
Guo et al. | Exome sequencing generates high quality data in non-target regions | |
CN109022553B (zh) | 用于肿瘤突变负荷检测的基因芯片及其制备方法和装置 | |
AU2013232123B2 (en) | Methods for analyzing massively parallel sequencing data for noninvasive prenatal diagnosis | |
Yost et al. | Identification of high-confidence somatic mutations in whole genome sequence of formalin-fixed breast cancer specimens | |
CN106414768B (zh) | 与癌症相关的基因融合体和基因变异体 | |
Xi et al. | Detecting structural variations in the human genome using next generation sequencing | |
CN108475300B (zh) | 利用癌症患者的基因组碱基序列突变信息和生存信息的定制型药物选择方法及*** | |
Sadowski et al. | Spatial chromatin architecture alteration by structural variations in human genomes at the population scale | |
WO2018144782A1 (en) | Methods of detecting somatic and germline variants in impure tumors | |
CN113948151B (zh) | 一种低深度wgs下机数据的处理方法 | |
JP2023504529A (ja) | がん予測パイプラインにおけるrna発現コールを自動化するためのシステムおよび方法 | |
AU2011207561A1 (en) | Partition defined detection methods | |
WO2020208181A1 (en) | Comprehensive detection of single cell genetic structural variations | |
US11718869B2 (en) | Method and kit for determining genome instability based on next generation sequencing (NGS) | |
KR20170000744A (ko) | 유전자의 복제수 변이(cnv)를 분석하는 방법 및 장치 | |
CN105986011B (zh) | 一种杂合性缺失的检测方法 | |
WO2022105629A1 (zh) | 一种用于检测样本污染水平的snp位点的筛选方法及样本污染水平的检测方法 | |
CN111223525A (zh) | 一种肿瘤外显子测序数据分析方法 | |
CN109461473B (zh) | 胎儿游离dna浓度获取方法和装置 | |
CN107208152B (zh) | 检测突变簇的方法和装置 | |
CN114517223B (zh) | 一种用于筛选snp位点的方法及其应用 | |
Esim et al. | Determination of malignant melanoma by analysis of variation values | |
WO2019226951A1 (en) | Methods to identify structural variations that cause diseases and the regions to repair with gene editing | |
CN111383713A (zh) | ctDNA检测分析装置及方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240401 Address after: 400000 1-2, 2-2, 3-2, 4-2, 5-2, 6-2, building 1, No. 6, Gangcheng East Ring Road, Jiangbei District, Chongqing Patentee after: MYGENOSTICS (CHONGQING) GENE TECHNOLOGY CO.,LTD. Country or region after: China Address before: 101312 201, block a, building 12, courtyard 9, Anqing street, airport economic core area, Shunyi District, Beijing Patentee before: BEIJING MYGENOSTICS CO.,LTD. Country or region before: China |
|
TR01 | Transfer of patent right |